Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-human Pilot Study of an Integrin α6-targeted Radiotracer for SPECT Imaging of Breast Cancer

NCT04289532 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT04289532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04289532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-human Pilot Study of an Integrin α6-targeted Radiotracer for SPECT Imaging of Breast Cancer
Lead sponsor
Peking University
Phase
Phase 1
Overall status
Completed
Start date
March 8, 2018
Completion date
June 30, 2019
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer